In postmenopausal women, drinking coffee-especially the decaffeinated brew-is inversely associated with the risk of developing type 2 diabetes, according to a study in the June 26 issue of the Archives of Internal Medicine.
In postmenopausal women, drinking coffee-especially the decaffeinated brew-is inversely associated with the risk of developing type 2 diabetes, according to a study in the June 26 issue of the Archives of Internal Medicine.
Mark A. Pereira, PhD, and colleagues at the University of Minnesota in Minneapolis, analyzed data from the 1986–1997 Iowa Women's Health Study, which included 28,812 postmenopausal women who did not have diabetes or cardiovascular disease. The women's daily coffee intake was divided into five groups: none, less than one cup a day, one to three cups, four to five cups, and six or more cups.
By the end of the study period, 1,418 cases of diabetes had occurred, and women who drank six or more cups of coffee a day had a 22% lower incidence compared to those who drank no coffee. The association was with the coffee itself, rather than caffeine intake, as it was most strongly associated with decaffeinated coffee. Moreover, there was no association between caffeine intake from all sources and diabetes, nor with intake of magnesium and phytate.
Pereira MA, Parker ED, Folsom AR. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28,812 postmenopausal women. Arch Intern Med. 2006;166:1311-1316.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More